CannBioRx Historical Balance Sheet

ATNFW Stock

USD 0.01 0.0007 8.43%

Trend analysis of CannBioRx Life Sciences balance sheet accounts such as Total Current Liabilities of 8.6 M, Other Assets of 0.0 or Cash And Short Term Investments of 1.7 M provides information on CannBioRx Life's total assets, liabilities, and equity, which is the actual value of CannBioRx Life Sciences to its prevalent stockholders. By breaking down trends over time using CannBioRx Life balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining CannBioRx Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether CannBioRx Life Sciences is a good buy for the upcoming year.

CannBioRx Life Inventory

(530,930)

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CannBioRx Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

About CannBioRx Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of CannBioRx Life Sciences at a specified time, usually calculated after every quarter, six months, or one year. CannBioRx Life Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of CannBioRx Life and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which CannBioRx currently owns. An asset can also be divided into two categories, current and non-current.

CannBioRx Life Balance Sheet Chart

At this time, CannBioRx Life's Short and Long Term Debt is fairly stable compared to the past year.

Total Assets Total Current Liabilities Cash And Short Term Investments Capital Surpluse

Total Assets

Total assets refers to the total amount of CannBioRx Life assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in CannBioRx Life Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on CannBioRx Life balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of CannBioRx Life Sciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of CannBioRx Life Sciences balance sheet. This account contains CannBioRx Life investments that will expire within one year. These investments include stocks and bonds that can be liquidated by CannBioRx Life Sciences fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most accounts from CannBioRx Life's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into CannBioRx Life Sciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CannBioRx Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

At this time, CannBioRx Life's Short and Long Term Debt is fairly stable compared to the past year.

	2022	2023	2024	2025 (projected)
Total Current Liabilities	5.7M	5.1M	5.8M	8.6M
Total Assets	19.7M	5.3M	4.7M	4.5M

Total Current Liabilities Total Assets

CannBioRx Life balance sheet Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Cash And Short Term Investments	Capital Surpluse	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Other Current Liab	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Stockholder Equity	Short Long Term Debt Total	Accounts Payable	Net Receivables	Good Will	Common Stock Total Equity	Inventory	Other Current Assets
Total Assets		0.25	0.45	0.14	0.87	0.64	0.4	0.11	0.87	0.85	0.27	0.02	0.07	0.1	-0.03	0.17	-0.03	0.26	-0.03	0.19	0.14	0.24	0.28	0.2	0.36	0.01
Total Current Liabilities	0.25		0.82	-0.5	-0.22	0.57	0.98	0.71	0.52	-0.25	0.89	-0.17	0.62	-0.57	-0.8	0.64	-0.78	-0.19	0.7	-0.27	0.06	0.82	-0.11	-0.15	0.64	0.72
Total Stockholder Equity	0.45	0.82		-0.17	-0.05	0.48	0.85	0.52	0.63	-0.08	0.76	-0.05	0.46	-0.28	-0.56	0.41	-0.56	0.19	0.43	0.02	0.08	0.67	0.23	0.21	0.67	0.39
Retained Earnings	0.14	-0.5	-0.17		0.27	-0.65	-0.47	-0.72	-0.13	0.3	-0.37	0.37	-0.64	0.98	0.9	-0.07	0.9	0.89	-0.95	0.93	0.53	-0.28	0.9	0.53	0.3	-0.83
Cash And Short Term Investments	0.87	-0.22	-0.05	0.27		0.42	-0.06	-0.17	0.61	1.0	-0.14	0.03	-0.17	0.29	0.29	-0.1	0.3	0.21	-0.29	0.2	0.07	-0.12	0.19	0.13	0.01	-0.22
Capital Surpluse	0.64	0.57	0.48	-0.65	0.42		0.66	0.57	0.79	0.39	0.43	-0.14	0.46	-0.69	-0.72	0.22	-0.73	-0.49	0.72	-0.54	-0.24	0.35	-0.48	-0.27	0.02	0.59
Total Liab	0.4	0.98	0.85	-0.47	-0.06	0.66		0.7	0.65	-0.1	0.87	-0.16	0.61	-0.55	-0.78	0.62	-0.76	-0.16	0.68	-0.24	0.07	0.82	-0.09	-0.15	0.62	0.68
Total Current Assets	0.11	0.71	0.52	-0.72	-0.17	0.57	0.7		0.2	-0.23	0.79	-0.77	0.98	-0.7	-0.8	0.14	-0.76	-0.39	0.76	-0.71	-0.53	0.72	-0.48	-0.18	0.23	0.91
Short Term Debt	0.87	0.52	0.63	-0.13	0.61	0.79	0.65	0.2		0.59	0.34	0.22	0.11	-0.23	-0.38	0.43	-0.39	0.03	0.31	0.07	0.27	0.38	0.07	0.01	0.34	0.14
Common Stock	0.85	-0.25	-0.08	0.3	1.0	0.39	-0.1	-0.23	0.59		-0.18	0.08	-0.23	0.32	0.34	-0.1	0.34	0.22	-0.33	0.24	0.1	-0.17	0.22	0.13	-0.01	-0.27
Other Current Liab	0.27	0.89	0.76	-0.37	-0.14	0.43	0.87	0.79	0.34	-0.18		-0.47	0.75	-0.38	-0.62	0.4	-0.58	-0.04	0.52	-0.28	-0.17	0.79	0.03	0.01	0.73	0.77
Net Debt	0.02	-0.17	-0.05	0.37	0.03	-0.14	-0.16	-0.77	0.22	0.08	-0.47		-0.85	0.26	0.28	0.29	0.21	0.14	-0.27	0.56	0.69	-0.42	0.32	0.01	-0.04	-0.61
Cash	0.07	0.62	0.46	-0.64	-0.17	0.46	0.61	0.98	0.11	-0.23	0.75	-0.85		-0.61	-0.71	0.04	-0.65	-0.3	0.66	-0.66	-0.57	0.71	-0.43	-0.16	0.21	0.85
Non Current Assets Total	0.1	-0.57	-0.28	0.98	0.29	-0.69	-0.55	-0.7	-0.23	0.32	-0.38	0.26	-0.61		0.94	-0.15	0.95	0.86	-0.98	0.86	0.44	-0.32	0.86	0.55	0.25	-0.79
Non Currrent Assets Other	-0.03	-0.8	-0.56	0.9	0.29	-0.72	-0.78	-0.8	-0.38	0.34	-0.62	0.28	-0.71	0.94		-0.34	1.0	0.65	-0.98	0.73	0.31	-0.57	0.65	0.38	-0.06	-0.83
Common Stock Shares Outstanding	0.17	0.64	0.41	-0.07	-0.1	0.22	0.62	0.14	0.43	-0.1	0.4	0.29	0.04	-0.15	-0.34		-0.31	0.09	0.22	0.21	0.73	0.66	0.13	0.07	0.6	0.14
Short Term Investments	-0.03	-0.78	-0.56	0.9	0.3	-0.73	-0.76	-0.76	-0.39	0.34	-0.58	0.21	-0.65	0.95	1.0	-0.31		0.67	-0.99	0.72	0.31	-0.5	0.65	0.41	-0.02	-0.81
Non Current Liabilities Total	0.26	-0.19	0.19	0.89	0.21	-0.49	-0.16	-0.39	0.03	0.22	-0.04	0.14	-0.3	0.86	0.65	0.09	0.67		-0.78	0.86	0.5	0.11	0.93	0.72	0.55	-0.63
Other Stockholder Equity	-0.03	0.7	0.43	-0.95	-0.29	0.72	0.68	0.76	0.31	-0.33	0.52	-0.27	0.66	-0.98	-0.98	0.22	-0.99	-0.78		-0.81	-0.41	0.43	-0.76	-0.52	-0.09	0.84
Short Long Term Debt Total	0.19	-0.27	0.02	0.93	0.2	-0.54	-0.24	-0.71	0.07	0.24	-0.28	0.56	-0.66	0.86	0.73	0.21	0.72	0.86	-0.81		0.76	-0.1	0.9	0.47	0.42	-0.81
Accounts Payable	0.14	0.06	0.08	0.53	0.07	-0.24	0.07	-0.53	0.27	0.1	-0.17	0.69	-0.57	0.44	0.31	0.73	0.31	0.5	-0.41	0.76		0.17	0.55	0.27	0.42	-0.56
Net Receivables	0.24	0.82	0.67	-0.28	-0.12	0.35	0.82	0.72	0.38	-0.17	0.79	-0.42	0.71	-0.32	-0.57	0.66	-0.5	0.11	0.43	-0.1	0.17		0.01	0.06	0.66	0.53
Good Will	0.28	-0.11	0.23	0.9	0.19	-0.48	-0.09	-0.48	0.07	0.22	0.03	0.32	-0.43	0.86	0.65	0.13	0.65	0.93	-0.76	0.9	0.55	0.01		0.62	0.65	-0.58
Common Stock Total Equity	0.2	-0.15	0.21	0.53	0.13	-0.27	-0.15	-0.18	0.01	0.13	0.01	0.01	-0.16	0.55	0.38	0.07	0.41	0.72	-0.52	0.47	0.27	0.06	0.62		0.38	-0.39
Inventory	0.36	0.64	0.67	0.3	0.01	0.02	0.62	0.23	0.34	-0.01	0.73	-0.04	0.21	0.25	-0.06	0.6	-0.02	0.55	-0.09	0.42	0.42	0.66	0.65	0.38		0.17
Other Current Assets	0.01	0.72	0.39	-0.83	-0.22	0.59	0.68	0.91	0.14	-0.27	0.77	-0.61	0.85	-0.79	-0.83	0.14	-0.81	-0.63	0.84	-0.81	-0.56	0.53	-0.58	-0.39	0.17

Click cells to compare fundamentals

CannBioRx Life Account Relationship Matchups

CannBioRx Life balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	55.5M	62.7M	19.7M	5.3M	4.7M	4.5M
Total Current Liabilities	21.4M	19.7M	5.7M	5.1M	5.8M	8.6M
Total Stockholder Equity	30.3M	39.3M	11.3M	(127.7K)	(146.9K)	(139.5K)
Retained Earnings	(48.4M)	(68.7M)	(107.4M)	(127.3M)	(114.6M)	(108.9M)
Cash And Short Term Investments	2.1M	8.2M	7.0M	2.0M	1.8M	1.7M
Total Liab	25.2M	23.4M	8.3M	5.4M	6.2M	11.6M
Total Current Assets	4.0M	11.2M	8.9M	3.6M	4.2M	4.0M
Short Term Debt	3.7M	1.9M	1.3M	1.0M	930.7K	1.5M
Common Stock	2.6K	3.4K	375.0	54.0	48.6	46.17
Other Current Liab	9.2M	17.2M	2.5M	2.1M	2.5M	2.3M
Net Debt	1.7M	(6.3M)	(5.6M)	(921.7K)	(829.6K)	(871.0K)
Cash	2.1M	8.2M	7.0M	2.0M	2.3M	3.2M
Non Current Assets Total	51.5M	51.5M	10.7M	1.6M	1.5M	1.4M
Common Stock Shares Outstanding	26.2M	82.5K	100.0K	379.1K	436.0K	414.2K
Liabilities And Stockholders Equity	55.5M	62.7M	19.7M	5.3M	4.7M	4.5M
Non Current Liabilities Total	3.8M	3.7M	2.6M	324.6K	292.1K	277.5K
Other Stockholder Equity	78.0M	107.2M	121.6M	130.1M	149.6M	157.1M
Short Long Term Debt Total	3.8M	2.0M	1.3M	1.1M	948.7K	1.9M
Accounts Payable	8.5M	586.6K	1.8M	1.9M	1.7M	2.7M
Net Receivables	784.6K	694.6K	621.0K	279.0K	251.1K	433.2K
Other Current Assets	1.1M	3.0M	1.3M	1.7M	1.9M	1.6M
Net Invested Capital	34.1M	41.3M	12.7M	926.3K	833.7K	792.0K
Short Long Term Debt	3.7M	1.9M	1.3M	1.0M	930.7K	1.8M
Accumulated Other Comprehensive Income	636.9K	817.4K	(2.9M)	(2.9M)	(2.6M)	(2.5M)
Capital Stock	2.6K	3.4K	375.0	54.0	48.6	46.17
Net Working Capital	(17.4M)	(8.5M)	3.3M	(1.4M)	(1.6M)	(1.7M)
Intangible Assets	14.6M	14.5M	10.7M	1.6M	1.5M	1.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for CannBioRx Stock Analysis

When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CannBioRx Historical Balance Sheet

CannBioRx Life Inventory

(530,930)

About CannBioRx Balance Sheet Analysis

CannBioRx Life Balance Sheet Chart

Total Assets

Total Current Liabilities

Cash And Short Term Investments

CannBioRx Life balance sheet Correlations

CannBioRx Life Account Relationship Matchups

High Positive Relationship

High Negative Relationship

CannBioRx Life balance sheet Accounts

Also Currently Popular

Additional Tools for CannBioRx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Cash And Short Term Investments
Short Term Investments	+ 1.0	Non Currrent Assets Other
Total Liab	+ 0.98	Total Current Liabilities
Non Current Assets Total	+ 0.98	Retained Earnings
Cash	+ 0.98	Total Current Assets
Short Term Investments	+ 0.95	Non Current Assets Total

Other Stockholder Equity	- 0.99	Short Term Investments
Other Stockholder Equity	- 0.98	Non Currrent Assets Other
Other Stockholder Equity	- 0.98	Non Current Assets Total
Other Stockholder Equity	- 0.95	Retained Earnings
Cash	- 0.85	Net Debt
Other Current Assets	- 0.83	Non Currrent Assets Other